Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis

被引：0
|
作者：
Florence R. Wilson
Megan E. Coombes
Christine Brezden-Masley
Mariya Yurchenko
Quinlan Wylie
Reuben Douma
Abhishek Varu
Brian Hutton
Becky Skidmore
Chris Cameron
机构：
[1] Cornerstone Research Group Inc.,Public Health and Preventative Medicine
[2] Hoffmann-La Roche Limited,undefined
[3] St. Michael’s Hospital,undefined
[4] Ottawa Hospital Research Institute,undefined
[5] University of Ottawa School of Epidemiology,undefined
[6] Independent Information Specialist,undefined
来源：
Systematic Reviews | / 7卷
关键词：
Early breast cancer; HER2-positive breast cancer; Network meta-analysis; Survival; Systematic review; Trastuzumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis
    Wilson, Florence R.
    Coombes, Megan E.
    Brezden-Masley, Christine
    Yurchenko, Mariya
    Wylie, Quinlan
    Douma, Reuben
    Varu, Abhishek
    Hutton, Brian
    Skidmore, Becky
    Cameron, Chris
    [J]. SYSTEMATIC REVIEWS, 2018, 7
  • [2] Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis
    Wilson, Florence R.
    Coombes, Megan E.
    Wylie, Quinlan
    Yurchenko, Mariya
    Brezden-Masley, Christine
    Hutton, Brian
    Skidmore, Becky
    Cameron, Chris
    [J]. SYSTEMATIC REVIEWS, 2017, 6
  • [3] Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis
    Florence R. Wilson
    Megan E. Coombes
    Quinlan Wylie
    Mariya Yurchenko
    Christine Brezden-Masley
    Brian Hutton
    Becky Skidmore
    Chris Cameron
    [J]. Systematic Reviews, 6
  • [4] Trastuzumab biosimilars vs trastuzumab originator in the treatment of HER2-positive breast cancer: a systematic review and network meta-analysis
    Liu, Tong
    Liu, Duo
    Jin, Yao
    Dong, Mei
    [J]. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2022, 44 (06) : 809 - 815
  • [5] Trastuzumab (herceptin) and HER2-positive breast cancer
    Murray, S
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 174 (01) : 36 - 37
  • [6] Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis
    Genuino, Anne Julienne
    Chaikledkaew, Usa
    The, Due Ong
    Reungwetwattana, Thanyanan
    Thakkinstian, Ammarin
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (08) : 815 - 824
  • [7] Trastuzumab deruxtecan for HER2-positive breast cancer brain metastasis: A systematic review and meta-analysis
    Michelon, I. F.
    Vilbert, M. Silveira
    Marinho, A. D.
    Castro, C. E. D. R.
    Dacoregio, M. I.
    Stecca, C.
    Soares, L. R.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S357 - S357
  • [8] Trastuzumab uptake in HER2-positive breast cancer patients: a systematic review and meta-analysis of observational studies
    Martin, Antony P.
    Downing, Jennifer
    Cochrane, Madeleine
    Collins, Brendan
    Francis, Ben
    Haycox, Alan
    Alfirevic, Ana
    Pirmohamed, Munir
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 130 : 92 - 107
  • [9] TRASTUZUMAB UPTAKE IN HER2-POSITIVE BREAST CANCER PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES
    Martin, A. P.
    Downing, J.
    Collins, B.
    Cochrane, M.
    Francis, B.
    Haycox, A.
    Alfirevic, A.
    Pirmohamed, M.
    [J]. VALUE IN HEALTH, 2018, 21 : S43 - S43
  • [10] Trastuzumab combined to neoadjuvant chemotherapy in patients with HER2-positive breast cancer: A systematic review and meta-analysis
    Valachis, Antonis
    Mauri, Davide
    Polyzos, Nikolaos P.
    Chlouverakis, Grigoris
    Mavroudis, Dimitrios
    Georgoulias, Vassilios
    [J]. BREAST, 2011, 20 (06): : 485 - 490
12345